The neurohormone melatonin as a marker, medicament, and mediator

Alfred Lewy, Jonathan Emens, J. Songer, J. Rough

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

This chapter is an update of what was originally published several years ago (Vessely and Lewy, 2002). Melatonin is a hormone produced by the pineal gland during nighttime darkness under the control of the endogenous circadian pacemaker (ECP) in the suprachiasmatic nucleus of the hypothalamus. The ECP is entrained (synchronized) to the 24-h light/dark cycle. The endogenous melatonin profile can be used to assess the phase position (time) of the ECP, and both bright light exposure and exogenous melatonin can influence its phase. Totally blind people often have free-running circadian rhythms that are not entrained to the 24-h light/dark cycle. In these blind free-runners (BFRs), circadian phase drifts each day, causing recurrent insomnia; properly timed low-dose melatonin can entrain BFRs to the 24-h day. Sighted people can have circadianrhythm disturbances as well. Both light and melatonin can be used to delay or advance circadian rhythms that are out of phase due to jet travel, shift work, or advanced or delayed sleep phase syndromes. Another group of people with circadian rhythm disorders are those suffering from seasonal affective disorder (SAD), or winter depression. Most people with SAD have circadian rhythms that delay in the winter, causing them to develop depressed moods and vegetative symptoms; light therapy timed to cause phase advances can lead to clear improvement. Preliminary work suggests that low-dose melatonin therapy may also be beneficial in treating SAD. The function of endogenous melatonin in humans may be to entrain the third-trimester fetus and suckling newborn to the mother's sleep/wake cycle.

Original languageEnglish (US)
Title of host publicationHormones, Brain and Behavior Online
PublisherElsevier Inc.
Pages2505-2528
Number of pages24
ISBN (Print)9780080887838
DOIs
StatePublished - 2010

Fingerprint

Melatonin
Neurotransmitter Agents
Seasonal Affective Disorder
Circadian Rhythm
Circadian Rhythm Sleep Disorders
Photoperiod
Chronobiology Disorders
Light
Suprachiasmatic Nucleus
Phototherapy
Pineal Gland
Darkness
Third Pregnancy Trimester
Sleep Initiation and Maintenance Disorders
Hypothalamus
Sleep
Fetus
Hormones
Depression

Keywords

  • Advanced sleep phase syndrome (ASPS)
  • Blindness, circadian rhythms
  • Bright light
  • Delayed sleep phase syndrome (DSPS)
  • Depression
  • Dim light melatonin onset (DLMO)
  • Jet lag
  • Light
  • Melatonin
  • Phase response curve to light
  • Phase response curve to melatonin
  • Seasonal affective disorder (SAD)
  • Shift work
  • Winter depression

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lewy, A., Emens, J., Songer, J., & Rough, J. (2010). The neurohormone melatonin as a marker, medicament, and mediator. In Hormones, Brain and Behavior Online (pp. 2505-2528). Elsevier Inc.. https://doi.org/10.1016/B978-008088783-8.00080-2

The neurohormone melatonin as a marker, medicament, and mediator. / Lewy, Alfred; Emens, Jonathan; Songer, J.; Rough, J.

Hormones, Brain and Behavior Online. Elsevier Inc., 2010. p. 2505-2528.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lewy, A, Emens, J, Songer, J & Rough, J 2010, The neurohormone melatonin as a marker, medicament, and mediator. in Hormones, Brain and Behavior Online. Elsevier Inc., pp. 2505-2528. https://doi.org/10.1016/B978-008088783-8.00080-2
Lewy A, Emens J, Songer J, Rough J. The neurohormone melatonin as a marker, medicament, and mediator. In Hormones, Brain and Behavior Online. Elsevier Inc. 2010. p. 2505-2528 https://doi.org/10.1016/B978-008088783-8.00080-2
Lewy, Alfred ; Emens, Jonathan ; Songer, J. ; Rough, J. / The neurohormone melatonin as a marker, medicament, and mediator. Hormones, Brain and Behavior Online. Elsevier Inc., 2010. pp. 2505-2528
@inbook{6923ffb7c32449ecb762b7fa49957343,
title = "The neurohormone melatonin as a marker, medicament, and mediator",
abstract = "This chapter is an update of what was originally published several years ago (Vessely and Lewy, 2002). Melatonin is a hormone produced by the pineal gland during nighttime darkness under the control of the endogenous circadian pacemaker (ECP) in the suprachiasmatic nucleus of the hypothalamus. The ECP is entrained (synchronized) to the 24-h light/dark cycle. The endogenous melatonin profile can be used to assess the phase position (time) of the ECP, and both bright light exposure and exogenous melatonin can influence its phase. Totally blind people often have free-running circadian rhythms that are not entrained to the 24-h light/dark cycle. In these blind free-runners (BFRs), circadian phase drifts each day, causing recurrent insomnia; properly timed low-dose melatonin can entrain BFRs to the 24-h day. Sighted people can have circadianrhythm disturbances as well. Both light and melatonin can be used to delay or advance circadian rhythms that are out of phase due to jet travel, shift work, or advanced or delayed sleep phase syndromes. Another group of people with circadian rhythm disorders are those suffering from seasonal affective disorder (SAD), or winter depression. Most people with SAD have circadian rhythms that delay in the winter, causing them to develop depressed moods and vegetative symptoms; light therapy timed to cause phase advances can lead to clear improvement. Preliminary work suggests that low-dose melatonin therapy may also be beneficial in treating SAD. The function of endogenous melatonin in humans may be to entrain the third-trimester fetus and suckling newborn to the mother's sleep/wake cycle.",
keywords = "Advanced sleep phase syndrome (ASPS), Blindness, circadian rhythms, Bright light, Delayed sleep phase syndrome (DSPS), Depression, Dim light melatonin onset (DLMO), Jet lag, Light, Melatonin, Phase response curve to light, Phase response curve to melatonin, Seasonal affective disorder (SAD), Shift work, Winter depression",
author = "Alfred Lewy and Jonathan Emens and J. Songer and J. Rough",
year = "2010",
doi = "10.1016/B978-008088783-8.00080-2",
language = "English (US)",
isbn = "9780080887838",
pages = "2505--2528",
booktitle = "Hormones, Brain and Behavior Online",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The neurohormone melatonin as a marker, medicament, and mediator

AU - Lewy, Alfred

AU - Emens, Jonathan

AU - Songer, J.

AU - Rough, J.

PY - 2010

Y1 - 2010

N2 - This chapter is an update of what was originally published several years ago (Vessely and Lewy, 2002). Melatonin is a hormone produced by the pineal gland during nighttime darkness under the control of the endogenous circadian pacemaker (ECP) in the suprachiasmatic nucleus of the hypothalamus. The ECP is entrained (synchronized) to the 24-h light/dark cycle. The endogenous melatonin profile can be used to assess the phase position (time) of the ECP, and both bright light exposure and exogenous melatonin can influence its phase. Totally blind people often have free-running circadian rhythms that are not entrained to the 24-h light/dark cycle. In these blind free-runners (BFRs), circadian phase drifts each day, causing recurrent insomnia; properly timed low-dose melatonin can entrain BFRs to the 24-h day. Sighted people can have circadianrhythm disturbances as well. Both light and melatonin can be used to delay or advance circadian rhythms that are out of phase due to jet travel, shift work, or advanced or delayed sleep phase syndromes. Another group of people with circadian rhythm disorders are those suffering from seasonal affective disorder (SAD), or winter depression. Most people with SAD have circadian rhythms that delay in the winter, causing them to develop depressed moods and vegetative symptoms; light therapy timed to cause phase advances can lead to clear improvement. Preliminary work suggests that low-dose melatonin therapy may also be beneficial in treating SAD. The function of endogenous melatonin in humans may be to entrain the third-trimester fetus and suckling newborn to the mother's sleep/wake cycle.

AB - This chapter is an update of what was originally published several years ago (Vessely and Lewy, 2002). Melatonin is a hormone produced by the pineal gland during nighttime darkness under the control of the endogenous circadian pacemaker (ECP) in the suprachiasmatic nucleus of the hypothalamus. The ECP is entrained (synchronized) to the 24-h light/dark cycle. The endogenous melatonin profile can be used to assess the phase position (time) of the ECP, and both bright light exposure and exogenous melatonin can influence its phase. Totally blind people often have free-running circadian rhythms that are not entrained to the 24-h light/dark cycle. In these blind free-runners (BFRs), circadian phase drifts each day, causing recurrent insomnia; properly timed low-dose melatonin can entrain BFRs to the 24-h day. Sighted people can have circadianrhythm disturbances as well. Both light and melatonin can be used to delay or advance circadian rhythms that are out of phase due to jet travel, shift work, or advanced or delayed sleep phase syndromes. Another group of people with circadian rhythm disorders are those suffering from seasonal affective disorder (SAD), or winter depression. Most people with SAD have circadian rhythms that delay in the winter, causing them to develop depressed moods and vegetative symptoms; light therapy timed to cause phase advances can lead to clear improvement. Preliminary work suggests that low-dose melatonin therapy may also be beneficial in treating SAD. The function of endogenous melatonin in humans may be to entrain the third-trimester fetus and suckling newborn to the mother's sleep/wake cycle.

KW - Advanced sleep phase syndrome (ASPS)

KW - Blindness, circadian rhythms

KW - Bright light

KW - Delayed sleep phase syndrome (DSPS)

KW - Depression

KW - Dim light melatonin onset (DLMO)

KW - Jet lag

KW - Light

KW - Melatonin

KW - Phase response curve to light

KW - Phase response curve to melatonin

KW - Seasonal affective disorder (SAD)

KW - Shift work

KW - Winter depression

UR - http://www.scopus.com/inward/record.url?scp=84884762783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884762783&partnerID=8YFLogxK

U2 - 10.1016/B978-008088783-8.00080-2

DO - 10.1016/B978-008088783-8.00080-2

M3 - Chapter

AN - SCOPUS:84884762783

SN - 9780080887838

SP - 2505

EP - 2528

BT - Hormones, Brain and Behavior Online

PB - Elsevier Inc.

ER -